Skip to main
SMMT
SMMT logo

Summit Therapeutics (SMMT) Market Capitalization Overview

Market Cap: $18.38B as of Jul 9, 2025

$18.38B
Past Month+$3.19B (20.97%)
As of Jul 9, 2025, Summit Therapeutics (SMMT) has a market capitalization of $18.38B. Over the past 30 days, its market cap has increased by 20.41%, while in the last 12 months, it has increased by 39.69%.

Market capitalization represents the total value of Summit Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Summit Therapeutics (SMMT) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Summit Therapeutics (SMMT) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Summit Therapeutics (SMMT) Market Cap History

DateMarket CapChange
Jul 1, 2025$15.75B+20.41%
Jun 2, 2025$13.08B-28.15%
May 1, 2025$18.20B+31.23%
Apr 1, 2025$13.87B-1.73%
Mar 3, 2025$14.12B-4.19%
Feb 3, 2025$14.73B+8.88%
Jan 2, 2025$13.53B-0.76%

Summit Therapeutics (SMMT) End of Year Market Cap History

DateMarket CapChange
2025$18.38B+39.69%
2024$13.16B+622.17%
2023$1.83B+112.88%
2022$855.62M+225.80%
2021$262.63M-32.07%
2020$386.63M

FAQs About Summit Therapeutics (SMMT) Market Cap

As of Jul 9, 2025, the market capitalization of Summit Therapeutics (SMMT) is $18.38B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Summit Therapeutics’s market capitalization has increased by 20.97%, changing from $15.19B to $18.38B as of Jul 9, 2025.

In the last 3 months, Summit Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Summit Therapeutics’s market capitalization increased from $1.83B in January to $13.16B in December, reflecting a 622.17% change.

In the past five years, Summit Therapeutics (SMMT) has had a compound annual growth rate (CAGR) of 102.47% in market capitalization. This means its market cap has grown at an average rate of 102.47% per year.

Summit Therapeutics (SMMT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.